Want to join the conversation?
$MRK's net cash provided by operating activities for 2015 rose to $12.4Bil from $7.9Bil in 2014. Cash used in investing activities grew to $4.8Bil from $374MM, on cash received in 2014 from divestiture of MCC, higher cash received in 2014 from other dispositions related to AstraZeneca's option exercise, and cash used for purchase of Cubist.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.